Literature DB >> 2344158

Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime.

E Yourassowsky1, M P van der Linden, F Crokaert.   

Abstract

Cephalosporins have been recommended as prophylactic antibiotics in patients undergoing cardiovascular surgery. The major function of these antibiotics is to protect patients against Staphylococcus aureus and Staphylococcus epidermidis infections. The lowest inoculum amount responsible for infection during surgery is unknown but is probably low. To determine the comparative activities of cefazolin, cefuroxime, and cefamandole against S. aureus and S. epidermidis for prophylactic purposes, we selected five strains of S. aureus and S. epidermidis that presented homogeneous resistances to oxacillin. A continuously monitored turbidimetric method was used to evaluate cultures with variable inoculum sizes ranging from 10(6) to 1 CFU/ml and exposed to cefazolin, cefuroxime, and cefamandole at concentrations of 0.5, 1, 2, 4, 8, 16, and 32 micrograms/ml. Growth was defined as an increase of 0.1 optical density unit. The relationship between the time required for growth, the antibiotic concentration, and the initial bacterial density showed that cefamandole was more active than cefazolin, which, in turn, was revealed to be more active than cefuroxime against S. aureus and S. epidermidis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344158      PMCID: PMC171633          DOI: 10.1128/AAC.34.4.505

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

Review 1.  Reappraisal of the antistaphylococcal activities of first-generation (narrow-spectrum) and second-generation (expanded-spectrum) cephalosporins.

Authors:  L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

2.  Characterization of resistance phenotype and cephalosporin activity in oxacillin-resistant Staphylococcus aureus.

Authors:  M Mateos-Mora; C C Knapp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

3.  Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.

Authors:  C W Stratton; C Liu; L S Weeks
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

4.  Evaluation of laboratory tests for detection of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  P E Coudron; D L Jones; H P Dalton; G L Archer
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

Review 5.  Antimicrobial prophylaxis in surgery.

Authors:  A B Kaiser
Journal:  N Engl J Med       Date:  1986-10-30       Impact factor: 91.245

Review 6.  Methicillin-resistant staphylococci.

Authors:  H F Chambers
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 7.  Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci.

Authors:  M A Pfaller; L A Herwaldt
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

8.  Randomized comparison of cefamandole, cefazolin, and cefuroxime prophylaxis in open-heart surgery.

Authors:  T G Slama; S J Sklar; J Misinski; S W Fess
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

9.  Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients.

Authors:  A B Kaiser; M R Petracek; J W Lea; D S Kernodle; A C Roach; W C Alford; G R Burrus; D M Glassford; C S Thomas; W S Stoney
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

10.  Relationship between cefamandole and cefuroxime activity against oxacillin-resistant Staphylococcus epidermidis and oxacillin resistance phenotype.

Authors:  G L Woods; C C Knapp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

View more
  3 in total

1.  Effect of subinhibitory concentrations of cefamandole and cefuroxime on adherence of Staphylococcus aureus and Staphylococcus epidermidis to polystyrene culture plates.

Authors:  H Carsenti-Etesse; J Durant; E Bernard; V Mondain; J Entenza; P Dellamonica
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

2.  Prophylaxis with teicoplanin and cefuroxime reduces the rate of prosthetic joint infection after primary arthroplasty.

Authors:  Eduard Tornero; Sebastian García-Ramiro; Juan C Martínez-Pastor; Guillem Bori; Jordi Bosch; Laura Morata; Marta Sala; Misericordia Basora; Josep Mensa; Alex Soriano
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

3.  Cefuroxime prophylaxis in cardiovascular surgery: clinical, microbiological, and ecological impact.

Authors:  L O Gentry; S M Birovljev; B Radovancević; D A Cooley
Journal:  Tex Heart Inst J       Date:  1992
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.